John K. Walker
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
-
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
Papers in ⓘ
-
- Phenothiazines and Benzothiazines Synthesis and Activities 7
- Receptor Mechanisms and Signaling 5
- Melanoma and MAPK Pathways 4
-
- Synthesis and biological activity 5
- Co-authors
- Helen I. Zgurskaya (14 shared papers)Jerry M. Parks (8 shared papers)Valentin V. Rybenkov (8 shared papers)Thomas P. Burris (8 shared papers)Arindam Chatterjee (6 shared papers)Bahaa Elgendy (4 shared papers)Melissa Kazantzis (2 shared papers)David Wolloscheck (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (6 papers)ACS Infectious Diseases (6 papers)The Journal of Immunology (2 papers)ACS Chemical Biology (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
John K. Walker
48 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 98
- Molecular Medicine 216
- Cancer Research 114
- Microbiology 46
- Molecular Biology 483
- Organic Chemistry 193
Countries citing papers authored by John K. Walker
This map shows the geographic impact of John K. Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John K. Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John K. Walker more than expected).
Fields of papers citing papers by John K. Walker
This network shows the impact of papers produced by John K. Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John K. Walker. The network helps show where John K. Walker may publish in the future.
Co-authors
The 25 scholars most cited alongside John K. Walker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 160 | |
| 2 | 2019 | 92 | |
| 3 | 2016 | 78 | |
| 4 | 2018 | 60 | |
| 5 | 1977 | 47 | |
| 6 | 2009 | 43 | |
| 7 | 2017 | 36 | |
| 8 | 1994 | 36 | |
| 9 | 2021 | 35 | |
| 10 | 2020 | 34 | |
| 11 | 2011 | 32 | |
| 12 | 2015 | 30 | |
| 13 | 2020 | 23 | |
| 14 | 2010 | 21 | |
| 15 | 2020 | 21 | |
| 16 | 2001 | 21 | |
| 17 | 1997 | 21 | |
| 18 | 2022 | 20 | |
| 19 | 2010 | 19 | |
| 20 | 2023 | 19 |
About John K. Walker
John K. Walker is a scholar working on Molecular Biology, Organic Chemistry, Molecular Medicine, Immunology and Genetics, having authored 49 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (10 papers), Phenothiazines and Benzothiazines Synthesis and Activities (7 papers), Receptor Mechanisms and Signaling (5 papers), Synthesis and biological activity (5 papers), Melanoma and MAPK Pathways (4 papers), Estrogen and related hormone effects (4 papers), Computational Drug Discovery Methods (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). The work is most often cited by research in Molecular Medicine (216 citations), Cancer Research (114 citations), Microbiology (46 citations), Molecular Biology (483 citations) and Organic Chemistry (193 citations). John K. Walker has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Helen I. Zgurskaya, Jerry M. Parks, Valentin V. Rybenkov, Thomas P. Burris, Arindam Chatterjee, Bahaa Elgendy, Melissa Kazantzis, David Wolloscheck, Jeremy C. Smith and Connor J. Cooper. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, ACS Infectious Diseases, The Journal of Immunology, ACS Chemical Biology and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.